Clinical Trial Update: Study Of The Efficacy And Security Of Ibandronate For Osteoporosis Treatment In A HIV-Infected Patients Cohort [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating ibandronate for osteoporosis in HIV-infected patients was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections
• Osteoporosis

Drugs mentioned

• Ibandronate (ibandronate)

Snippet

Sponsor: Germans Trias i Pujol Hospital | Conditions: HIV Infections | Phase 4 | Status: WITHDRAWN